S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
[Urgent!] Generational Wealth Gameplan (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Did You Get Your Free Bitcoin Yet? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
Options trading has suddenly become more reliable. (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
[Urgent!] Generational Wealth Gameplan (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Did You Get Your Free Bitcoin Yet? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
Options trading has suddenly become more reliable. (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
[Urgent!] Generational Wealth Gameplan (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Did You Get Your Free Bitcoin Yet? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
Options trading has suddenly become more reliable. (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
[Urgent!] Generational Wealth Gameplan (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Did You Get Your Free Bitcoin Yet? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
Options trading has suddenly become more reliable. (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
NASDAQ:OTIC

Otonomy (OTIC) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free OTIC Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.0085
▼
$0.0085
50-Day Range
$0.01
▼
$0.12
52-Week Range
$0.01
▼
$2.54
Volume
N/A
Average Volume
937,525 shs
Market Capitalization
$582,479.50
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
OTIC stock logo

About Otonomy Stock (NASDAQ:OTIC)

Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm's product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA.

OTIC Stock News Headlines

January 23, 2023 | finance.yahoo.com
Otonomy, Inc. (OTIC) Stock Historical Prices & Data - Yahoo Finance
December 21, 2022 | finanznachrichten.de
Otonomy, Inc.: Otonomy Provides Corporate Update
April 18, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
December 19, 2022 | finance.yahoo.com
Otonomy Provides Corporate Update
November 30, 2022 | investorplace.com
5 Investors Betting Big on Otonomy (OTIC) Stock
November 29, 2022 | investorplace.com
Why Is Otonomy (OTIC) Stock Up 97% Today?
November 10, 2022 | finance.yahoo.com
Otonomy Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 6, 2022 | reuters.com
OTIC.OQ - Otonomy Inc | Stock Price & Latest News | Reuters
April 18, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
October 14, 2022 | marketscreener.com
OTONOMY, INC. : Results of Operations and Financial Condition (form 8-K) - Marketscreener.com
October 13, 2022 | investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.83% By Investing.com - Investing.com
October 13, 2022 | finance.yahoo.com
LianBio To Shut BridgeBio-Partnered Bile Duct Cancer Drug Trial - Yahoo Finance
October 13, 2022 | streetinsider.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.83% - StreetInsider.com
October 13, 2022 | benzinga.com
Otonomy shares are trading lower after the company reported higher dose cohorts for OTO-413 demonstrated no clinically meaningful improvement for patients from baseline. - Otonomy (NASDAQ:OTIC) - Benzinga
October 13, 2022 | marketscreener.com
Otonomy Sees No Clinically Meaningful Improvement With Higher Doses of OTO-413 in Patients With Hearing Loss -- Shares Nosedive - Marketscreener.com
October 13, 2022 | benzinga.com
Why Laser Photonics Shares Are Trading Higher By Around 44%, Here Are 50 Stocks Moving In Thursday’s Mid- - Benzinga
October 13, 2022 | marketscreener.com
Otonomy Sees No Clinically Meaningful Improvement With Higher Doses of OTO-413 in Patients With Hearing Loss - Marketscreener.com
October 13, 2022 | globenewswire.com
Otonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss - GlobeNewswire
October 13, 2022 | finance.yahoo.com
Otonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss - Yahoo Finance
October 13, 2022 | finance.yahoo.com
Otonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss
October 7, 2022 | reuters.com
OTIC.O - Otonomy Inc | Stock Price & Latest News | Reuters
September 27, 2022 | marketscreener.com
APPLIED GENETIC TECHNOLOGIES CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.com
September 17, 2022 | marketscreener.com
OTONOMY, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - Marketscreener.com
September 9, 2022 | streetinsider.com
Form SC 13G/A OTONOMY, INC. Filed by: FEDERATED HERMES, INC. - StreetInsider.com
September 1, 2022 | finance.yahoo.com
AGTC to Participate in Upcoming Investor Conferences - Yahoo Finance
August 11, 2022 | marketscreener.com
Otonomy : Costs Associated with Exit or Disposal Activities - Form 8-K - Marketscreener.com
August 9, 2022 | marketscreener.com
OTONOMY, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers (form 8-K) - Marketscreener.com
See More Headlines
Receive OTIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Otonomy and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
4/18/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OTIC
CUSIP
N/A
CIK
1493566
Web
www.otonomy.com
Phone
(619) 323-2200
Fax
619-291-9190
Employees
51
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.77)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-51,180,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-137.86%
Return on Assets
-68.50%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.74
Quick Ratio
1.74

Sales & Book Value

Annual Sales
$130,000.00
Price / Sales
4.48
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.97 per share
Price / Book
0.01

Miscellaneous

Outstanding Shares
68,527,000
Free Float
67,780,000
Market Cap
$582,479.50
Optionable
Optionable
Beta
1.54
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Paul E. Cayer
    President, CFO, Secretary & Chief Business Officer
  • Anna Stepannenko
    Vice President -Technical operations
  • Fabrice Piu
    Vice President-Research & Preclinical Development
  • David Skarinsky
    Vice President-Clinical
  • Jeffery J. Anderson
    Vice President-Clinical Sciences

Key Competitors

View All Competitors

OTIC Stock Analysis - Frequently Asked Questions

How were Otonomy's earnings last quarter?

Otonomy, Inc. (NASDAQ:OTIC) issued its quarterly earnings results on Wednesday, November, 10th. The biopharmaceutical company reported ($0.19) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.19). During the same period last year, the firm earned ($0.22) EPS.

What other stocks do shareholders of Otonomy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Otonomy investors own include BMO Capital Markets (), Stifel Nicolaus (), Wunderlich (), Standpoint Research (), Duncan Williams (), Soleil Securities (), Sterne Agee CRT (), Robert W. Baird (), Wellington Shields () and Macquarie ().

This page (NASDAQ:OTIC) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Biden replacement revealed?
Paradigm Press
The “Perfect Storm” for Gold
Gold Safe Exchange
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The Next Nvidia?
InvestorPlace